Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$616K Buy
4,770
+2,770
+139% +$335K ﹤0.01% 1469
2023
Q4
$229K Buy
+2,000
New +$200K ﹤0.01% 1573
2020
Q1
Sell
-3,509
Closed -$277K 969
2019
Q4
$277K Sell
3,509
-426
-11% -$33.2K 0.01% 745
2019
Q3
$315K Sell
3,935
-73
-2% -$5.74K 0.01% 670
2019
Q2
$334K Buy
+4,008
New +$319K 0.01% 678
2019
Q1
Sell
-4,164
Closed -$276K 1299
2018
Q4
$276K Buy
4,164
+1,235
+42% +$85.4K 0.02% 653
2018
Q3
$235K Buy
+2,929
New +$219K 0.01% 822

Other funds holding XYL

Cetera Advisors's XYL Position: Q1 2024 in Review

Cetera Advisors increased its Xylem (XYL) stake by 139% in Q1 2024, buying an estimated $335K and bringing the position to 4,770 shares worth $616K. The position accounts for ﹤0.01% of the portfolio, ranked #1469.

Cetera Advisors first reported a position in XYL in Q3 2018 and has held it in 7 quarters since. 990 funds tracked by Wall St. Rank hold XYL as of Q1 2024.

  • Cetera Advisors held 4,770 shares of Xylem worth $616K as of Q1 2024.
  • Cetera Advisors bought 2,770 Xylem shares in Q1 2024, an estimated $335K.
  • Xylem made up ﹤0.01% of Cetera Advisors's portfolio in Q1 2024, its #1469 holding.
  • Cetera Advisors first reported a position in Xylem in Q3 2018 and has held it in 7 quarters since.
  • 990 funds tracked by Wall St. Rank held Xylem as of Q1 2024.

Based on Cetera Advisors's 13F filing for Q1 2024, filed 15 May 2024.